Skip til primært indhold

Oncology

Choice of radiation dose

This is an English translation of the danish ”Valg af stråledosis” patient decision aid. Concerns patients planned to receive high dose stereotactic body radiation therapy for a tumor In the lung located less than 1 cm from the thoracic wall. The patients will be able to choose either high or lower radiation dose. A lower dose will decrease the risk of side effects, but local tumor control might also be decreased. The Danish patient decision aid is being tested in a local randomized trial, SDM Lung SBRT

Subject area   

Treatment, lung cancer or lung metastasis from another primary cancer

Options

  • High dose, 66 Gray in 3 fractions
  • Lower dose, 45 Gray in 3 fractions
  • No treatment
  • High dose, 66 Gray in 3 fractions, pall
  • Lover dose, 45 Gray in 3 fractions, pall
  • No treatment (pall)

Preparation sheet included 

Yes

Developed by

Department of Oncology, Lillebaelt Hospital in collaboration with CFFB

Responsible for update 

Physician, PhD-student Thomas Leth Fink, Department of Oncology, Lillebaelt Hospital

Version

1.3

Scheduled update

November 2023

Access to DECISION HELPER™

To access the watermarked preview of the finalized DECISION HELPER™ on choice of radiation dose (PDF), please follow the provided link.

To access the digital DECISION HELPER™ building platform, where DECISION HELPER™ is created, you must be an employee within a region in Denmark.

For any additional inquiries, please contact the Centre for Shared Decision Making: Maybritt Brunsgaard Klausen.

Based on IPDAS criteria (International Patient Decision Aid Standards) this decision aid (and/or supporting materials) meets:  

Six of six qualifying criteria are met

This Patient Decision Aid meets the IPDAS qualifying criteria to be defined as a Patient Decision Aid

Five of Five certifying criteria are met

Certifying criteria lower the risk of making a biased decision

Fourteen of seventeen quality criteria are met 

Quality criteria that strengthen the quality of the Patient Decision Aid

 

Only applicable criteria are included in the assessment

APPFWU01V